-The Hindu As a COVID-19 vaccine is for all age groups, putting in place an innovative delivery platform in time is a must Everyone eagerly asks: will we get a COVID-19 vaccine this year or only next year? During a pandemic, expecting vaccines the same year or the next, illustrates the power of technology, human hope, media hype — all at unprecedented frenzy. Where India stands Globally, innumerable vaccine trials are progressing; in India,...
More »SEARCH RESULT
Total Matching Records found : 50
Completion of trials could take at least 6 to 9 months, says Soumya Swaminathan -R Prasad
-The Hindu It is encouraging to see that at least seven Indian companies are developing COVID-19 vaccines. All of them must be tested ... and till we see results from these trials, we cannot predict which of them will be successful, says the Chief Scientist at WHO A day after scientists and experts raised serious concerns over Indian Council of Medical Research’s (ICMR) letter to all 12 principal investigators to speed up...
More »Under Ayushman Bharat, hospitals use bizarre ways to siphon off funds -Ishita Mishra
-The Economic Times Private hospitals have been accused of siphoning almost Rs 1.20 crore in just a few months. About a year after introduction of the Ayushman Bharat scheme — the Union government’s programme for providing health protection cover to around 10 crore vulnerable families — truant doctors and hospitals in the tiny Himalayan state of Uttarakhand have come up with some of the most innovative ways of scamming the ambitious plan...
More »Why should we not revoke Bollgard II patent, Centre asks Mahyco Monsanto -KV Kurmanath
-The Hindu Business Line Govt acts on a letter from farmers’ union on bollworm developing resistance to technology Hyderabad: Even as it announced a nation-wide uniform price for cottonseed for the upcoming kharif season, the Union government has asked Mahyco Monsanto Biotech (India) Limited why it should not revoke the patent it granted for the Bollgard II technology. The Department of Industry Policy and Promotion (DIPP) has served a show cause notice to...
More »Eye on safety, Govt defers GM mustard decision -Amitabh Sinha & Harish Damodaran
-The Indian Express Will not halt research but not rushing through decision, says Javadekar. HELPING THE government buy peace with activists protesting against granting clearance to the first transgenic food crop in the country, the biotechnology regulator on Friday deferred a decision on allowing the cultivation of a genetically-modified (GM) hybrid mustard. The Genetic Engineering Appraisal Committee (GEAC), a body under the Environment Ministry that regulates the use of genetically modified organisms (GMOs),...
More »
